Applications including "United States Pharmacopoeia Draft"

LC139 - Analysis of Naproxen (Under the Condition of draft for USP PF51(4), Naproxen Compounded Oral Suspension, ASSAY) -

LC InertSearch Inertsil ODS-EP
LC138 - Analysis of Acetaminophen (Under the Condition of draft for USP PF51(1), Acetaminophen Injection, ORGANIC IMPURITIES) -

LC InertSearch InertSustainSwift C18
LC137 - Analysis of Acetaminophen (Under the Condition of draft for USP PF52(1), Acetaminophen Injection, ASSAY) -

LC InertSearch InertSustainSwift C18
LC136 - Analysis of Olaparib (Under the Condition of draft for USP PF51(6), Olaparib Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC135 - Analysis of Edoxaban tosylate (Under the Condition of draft for USP, Edoxaban Tosylate, ORGANIC IMPURITIES) -

LC InertSearch Inertsil ODS-3
LC134 - Analysis of Edoxaban tosylate (Under the Condition of draft for USP, Edoxaban Tosylate, ASSAY) -

LC InertSearch Inertsil ODS-3
LC133 - Analysis of Carbidopa and Levodopa (Under the Condition of draft for USP, Carbidopa, Levodopa, and Entacapone Tablets, DISSOLUTION, Test for carbidopa and levodpa) -

LC InertSearch InertSustain C18
LC131 - Analysis of Entacapone (Under the Condition of draft for USP, Carbidopa, Levodopa, and Entacapone, ASSAY, PROCEDURE 2, ENTACAPONE ) -

LC InertSearch InertSustain C18
LC130 - Analysis of Carbidopa and Levodopa (Under the Condition of draft for USP, Carbidopa,Levodopa,and Entacapone Tablets, ASSAY, PROCEDURE 1, CARBIDOPA AND LEVODOPA) -

LC InertSearch InertSustainSwift C18
LC129 - Analysis of Olaparib (Under the Condition of draft for USP, Olaparib, ASSAY) -

LC InertSearch Inertsil Hybrid-C18
GA398 - Analysis of Diethoxymethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Polyoxymethylene Dimethyl Ether) -

GC InertSearch InertCap Pure-WAX
LC127 - Analysis of Biotin (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , BIOTIN) -

LC InertSearch InertSustainC8 InertSustain C8
LC123 - Analysis of Cyanocobalamin (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , CYANOCOBALAMIN) -

LC InertSearch InertSustainSwift C18
LC122 - Analysis of Niacinamide and Pyridoxine (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , NIACINAMIDE AND PYRIDOXINE, Method 1) -

LC InertSearch InertSustain AQ-C18
LC121 - Analysis of Folic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels ,FOLIC ACID Method 1) -

LC InertSearch InertSustain C8
LC113 - Analysis of Guanine (Under the Condition of draft for USP, Acyclovir Capsules, LIMIT OF GUANINE) -

LC InertSearch Inertsil WP300 C18
LC112 - Analysis of Acyclovir (Under the Condition of draft for USP, Acyclovir Capsules, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC111 - Analysis of Acyclovir (Under the Condition of draft for USP, Acyclovir for Injection, ASSAY) -

LC InertSearch Inertsil WP300 C18
GA397 - Analysis of Nitromethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Nitromethane) -

GC InertSearch InertCap 624MS
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC InertSearch InertSustain AQ-C18
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustainC18
LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC InertSearch InertCore C8
LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC InertSearch InertSustain C8
LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC InertSearch InertSustain C8
LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC InertSearch InertSustain C8
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC InertSearch InertSustainSwift C18
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC InertSearch InertSustainSwift C18
LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC InertSearch Inertsil NH2

Applications including "United States Pharmacopoeia Draft"

LC139 - Analysis of Naproxen (Under the Condition of draft for USP PF51(4), Naproxen Compounded Oral Suspension, ASSAY) -

LC138 - Analysis of Acetaminophen (Under the Condition of draft for USP PF51(1), Acetaminophen Injection, ORGANIC IMPURITIES) -

LC137 - Analysis of Acetaminophen (Under the Condition of draft for USP PF52(1), Acetaminophen Injection, ASSAY) -

LC136 - Analysis of Olaparib (Under the Condition of draft for USP PF51(6), Olaparib Tablets, ASSAY) -

LC135 - Analysis of Edoxaban tosylate (Under the Condition of draft for USP, Edoxaban Tosylate, ORGANIC IMPURITIES) -

LC134 - Analysis of Edoxaban tosylate (Under the Condition of draft for USP, Edoxaban Tosylate, ASSAY) -

LC133 - Analysis of Carbidopa and Levodopa (Under the Condition of draft for USP, Carbidopa, Levodopa, and Entacapone Tablets, DISSOLUTION, Test for carbidopa and levodpa) -

LC131 - Analysis of Entacapone (Under the Condition of draft for USP, Carbidopa, Levodopa, and Entacapone, ASSAY, PROCEDURE 2, ENTACAPONE ) -

LC130 - Analysis of Carbidopa and Levodopa (Under the Condition of draft for USP, Carbidopa,Levodopa,and Entacapone Tablets, ASSAY, PROCEDURE 1, CARBIDOPA AND LEVODOPA) -

LC129 - Analysis of Olaparib (Under the Condition of draft for USP, Olaparib, ASSAY) -

GA398 - Analysis of Diethoxymethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Polyoxymethylene Dimethyl Ether) -

LC127 - Analysis of Biotin (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , BIOTIN) -

LC123 - Analysis of Cyanocobalamin (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , CYANOCOBALAMIN) -

LC122 - Analysis of Niacinamide and Pyridoxine (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels , NIACINAMIDE AND PYRIDOXINE, Method 1) -

LC121 - Analysis of Folic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels ,FOLIC ACID Method 1) -

LC113 - Analysis of Guanine (Under the Condition of draft for USP, Acyclovir Capsules, LIMIT OF GUANINE) -

LC112 - Analysis of Acyclovir (Under the Condition of draft for USP, Acyclovir Capsules, ASSAY) -

LC111 - Analysis of Acyclovir (Under the Condition of draft for USP, Acyclovir for Injection, ASSAY) -

GA397 - Analysis of Nitromethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Nitromethane) -

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

Application Search